Novartis has made a dramatic return to the Huntington's disease therapy stage by licensing a candidate from PTC Therapeutics for a whopping $1 billion upfront. The deal – which has a potential total ...

I've upgraded PTC Inc. to a Buy at ~$179 per share after strong FQ4 2025 results, robust customer contract growth, and improved shareholder returns. PTC's focus on product lifecycle management, ...

PTC is selling off its IoT businesses, Kepware and ThingWorx, in order to hone its focus on SaaS and AI, according to CEO Neil Barua, as the conglomerate announced a sale of the operations to asset ...

Global software company PTC provides digital transformation solutions that specialize in computer-aided design and product lifecycle management to help businesses design and manufacture products ...

Goldman Sachs flags PTC Industries as a key APAC pick driven by titanium and aerospace growth catalysts. Goldman Sachs has added PTC Industries in its latest APAC Conviction List. The global brokerge ...

The premium tax credit is a refundable credit that helps some taxpayers afford health insurance premiums. The advance PTC lowers the premiums themselves. Many, or all, of the products featured on this ...

In the past week, Enlil Inc. announced new integrations with PTC Onshape, Dassault Systèmes SolidWorks, and Bill.com, enhancing connectivity for medical device development and regulatory compliance by ...

BOSTON, Sept. 16, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the release of its Arena ® product lifecycle management (PLM) and quality management system (QMS) Artificial Intelligence (AI) ...

Aug 19 (Reuters) - The U.S. Food and Drug Administration has denied approval for PTC Therapeutics' (PTCT.O), opens new tab oral medication for a rare genetic disorder with limited treatment options, ...

The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate ...

If Wall Street had any doubts about Neil Barua filling the shoes of his predecessor Jim Heppelmann as chief executive at PTC, those doubts went out the (computer-designed) window last week. The Boston ...